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Abstract
High mobility group box 1 (HMGB1) is a nuclear transcription factor. Once HMGB1 is released by damaged cells or activated
immune cells, it acts as danger molecule and triggers the inflammatory signaling cascade. Currently, evidence is
accumulating that posttranslational modifications such as oxidation may modulate the pro-inflammatory potential of
danger signals. We hypothesized that oxidation of HMGB1 may reduce its pro-inflammatory potential and could take place
during prolonged ischemia and upon reperfusion. Liver grafts were cold preserved for 24 h and flushed with saline in
hourly intervals to collect the effluent. Liver grafts, cold-preserved for 6 h, were transplanted into syngeneic recipients to
obtain serum and liver samples 24 h after initiation of reperfusion. Addition of the effluent to a macrophage culture induced
the synthesis of tumor necrosis factor-alpha (TNF-a) and interleukin (IL)-6. The stimulatory activity of graft effluent was
reduced after depletion of HMGB1 via immunoprecipitation. Oxidation of the effluent HMGB1 using H2O2 attenuated its
stimulatory activity as well. Liver transplantation of cold preserved grafts caused HMGB1 translocation and release as
determined by immunohistochemistry and ELISA-assay, respectively. Using Western blot with non-reducing conditions
revealed the presence of oxidized HMGB1 in liver samples obtained after 12 h and in effluent samples after 16 h of cold
preservation as well as in liver and serum samples obtained 24 h after reperfusion. These observations confirm that post-
translational oxidation of HMGB1 attenuates its pro-inflammatory activity. Oxidation of HMGB1 as induced during
prolonged ischemia and by reoxygenation during reperfusion in vivo might also attenuate its pro-inflammatory activity. Our
findings also call for future studies to investigate the mechanism of the inhibitory effect of oxidized HMGB1 on the pro-
inflammatory potential.
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Introduction
Liver transplantation is currently the only efficient treatment for
patients suffering from both acute and chronic liver disease.
Although significant progress in liver transplantation has been
made, primary graft dysfunction remains a problem. Injury
inflicted on the graft may result from harvesting, ischemia,
preservation and reperfusion.
Cold ischemia is an independent risk factor for primary
dysfunction and delayed graft function [1]. Cold ischemia activates
hepatic sinusoidal epithelial cells and Kupffer cells to produce
inflammatory cytokines and to express adhesion molecules [2,3].
Activation of the inflammatory response results in hepatic damage
upon liver transplantation. Activation of the inflammatory
cascades involves the release of danger signals from injured cells
and activated immune cells [4]. Up to now, an array of danger
signals has been identified with high mobility group box 1
(HMGB1) being the most widely explored [5–7].
HMGB1 was initially defined as a nuclear protein which loosely
binds to chromatin, and plays a pivotal role to bending DNA and
regulating transcription [8–10]. Recent studies have demonstrated
that HMGB1 also acts as a mediator of inflammation when
passively released by necrotic cells and actively secreted by
immune cells [8,11–14]. Immune cells, such as monocytes and
macrophages stimulated by lipopolysaccharide (LPS), tumor
necrosis factor-alpha (TNF-a) or interleukin (IL)-1 secrete
HMGB1 [11]. Serum HMGB1 levels are increased after
endotoxin exposure, and administration of anti-HMGB1 antibody
protects mice from LPS-induced death [11]. Serum levels of
HMGB1 are also elevated in patients with inflammatory diseases,
such as pancreatitis, arthritis, and hemorrhagic shock [15]. Recent
reports demonstrated that HMGB1 acts as an alarmin initiating
the inflammatory response resulting from ischemia/reperfusion (I/
R) injury in several organs, including liver, kidney, heart and brain
[16–21].
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35379HMGB1 can be subject to different types of post-translational
modification, including acetylation [22], phosphorylation [23],
methylation [24] and oxidation [25]. Recently, it is reported that
the immune response mediated by HMGB1, lies not simply in the
release of HMGB1, but rather in the oxidative state of the released
HMGB1 [26,27]. We demonstrated previously that HMGB1 was
released into the effluent during prolonged cold saline preservation
of liver grafts [28]. We also demonstrated that transplantation of a
cold-preserved liver graft did not interfere with spontaneous graft
acceptance [29]. These data indicate that HMGB1-release did not
result in continuing inflammatory injury in this setting.
In the present study, we aimed to test these hypotheses that
oxidation of HMGB1 may attenuate its inflammatory potential
and could take place during prolonged ischemia and liver
transplantation.
Results
Graft effluent induces pro-inflammatory cytokine
synthesis by cultured rat peritoneal macrophages
TNF-a and IL-6 are known to increase in serum and liver tissue
upon reperfusion and play pivotal role in the pathophysiology of
hepatic I/R injury [30,31]. To observe whether graft effluent may
induce TNF-a and IL-6 synthesis by macrophages, effluent
(100 ml) was added to cultured peritoneal macrophages for 6 h.
Subsequently, the levels of both inflammatory cytokines, TNF-a
and IL-6, in the supernatants and their mRNA expression in
macrophages were measured. There was no significant increase in
mRNA levels or secreted protein levels for TNF-a or IL-6 by
macrophages cultured with effluent collected at 0 h or 4 h after
cold preservation of livers. In contrast, effluent collected at 8 h,
12 h, 16 h or 24 h after cold preservation induced significant and
rising increases of both protein and mRNA levels for TNF-a and
IL-6 (p,0.05) (Fig. 1).
The stimulatory activity of graft effluent is attenuated
after the depletion of HMGB1
We previously reported that HMGB1 was released into effluent
during cold ischemia [28]. In the present study, HMGB1 levels in
the effluent were negligible at 0 h (1.560.4 ng/ml) and became
detectable as early as 8 h (36619 ng/ml), and then increased in a
time-dependent manner up to 24 h (18246680 ng/ml) (Fig. 2A).
These results were confirmed by western blot analysis showing that
the amount of HMGB1 present in effluent was elevated after 8 h
cold ischemia (Fig. 2B). Effluent with the highest concentration of
HMGB1, obtained after 24 h of cold storage, was selected for the
HMGB1 pro-inflammatory activity assay.
To determine whether effluent HMGB1 was biologically active
as a pro-inflammatory mediator, HMGB1 was depleted from
effluent using immunoprecipitation prior to stimulation, as shown
in Fig. 2C. The synthesis of TNF-a and IL-6 was reduced by about
60% when using effluent depleted of HMGB1 (Fig. 2D) in
comparison to complete effluent. This finding indicated that this
response was mainly mediated by effluent HMGB1.
Oxidation of HMGB1 attenuates its stimulatory activity in
cultured macrophages
To observe whether oxidized HMGB1 could neutralize its
stimulatory activity, HMGB1 was firstly extracted from effluent
obtained after 24 h of cold storage and oxidation of HMGB1 was
induced by pretreatment of the effluent HMGB1 with H2O2 prior
to stimulation. Oxidation of HMGB1 can induce a mobility shift
in non-reducing SDS-PAGE [25]. Immunoblotting showed that
the amount of oxidized HMGB1 was dramatically increased after
treatment with H2O2 (Fig. 3A–B). As shown in Fig. 3C–D, The
synthesis of TNF-a and IL-6 was reduced by approximately 80%
when using effluent HMGB1 pretreated with H2O2. This finding
indicated that inhibition of the pro-inflammatory activity was
mainly mediated by oxidation of HMGB1.
Oxidation of HMGB1 attenuates its stimulatory activity in
vivo
It was reported that administration of recombinant HMGB1
(rHMGB1) to mice induced sepsis and acute lung inflammation
[11,32]. Interestingly, administration of rHMGB1 (1.2 mg/kg) to
naive rats induced mRNA expression of TNF-a and IL-6 in lung
and PBMC, but not in liver, kidney and heart. We studied whether
administration of H2O2-oxidized HMGB1 could attenuate its
inflammatory activity in vivo. Indeed, the HMGB1-mediated
effect on the expression of inflammatory cytokines in lung and
PBMC was reduced when animals were treated with rHMGB1
subjected to H2O2 (Fig. 4).
HMGB1 expression is increased after liver transplantation
As shown in Fig. 5A, liver transplantation resulted in HMGB1
translocation from the nucleus to the cytoplasm in hepatocytes.
More than 50% of hepatocytes with cytoplasmic HMGB1 staining
were recorded after 24 h reperfusion. HMGB1 protein was
upregulated by liver cells, accounting for an approximately
twofold increase at 24 h after liver transplantation (Fig. 5B). Liver
transplantation also caused HMGB1 release. Serum HMGB1
levels were elevated by approximately fourfold at 24 h as
quantified using an ELISA-assay (Fig. 5C). Of note, serum
HMGB1 levels correlated with AST levels at 24 h after liver
transplantation (r=0.870, p=0.033; Fig. 5E). This finding
suggests that liver transplantation upregulated HMGB1 expres-
sion and serum HMGB1 was mainly released by damaged
hepatocytes.
Oxidation of HMGB1 occurs after prolonged cold storage
of the liver and after liver transplantation
To determine whether HMGB1 was oxidized after prolonged
cold ischemia and liver transplantation, effluent proteins, hepatic
proteins or serum proteins were firstly separated on non-reducing
SDS-PAGE and HMGB1 protein was detected by immunoblot-
ting. As shown in Fig. 6, oxidized HMGB1 was detected in cold
preserved ischemic liver grafts (Fig. 6A) and in the effluent
obtained from those livers (Fig. 6C). Total HMGB1 was slightly
increased 4 h after explantation, reached a maximum between
8 h and 12 h of cold storage and decreased thereafter, possibly
related to the loss of HMGB1 into the effluent. Oxidized
HMGB1 was significantly increased in liver samples obtained
after 12 h and in effluent samples after 16 h of cold preservation.
Band sizes for oxidized and reduced fraction of HMGB1 in liver
tissue were of similar thickness, whereas the fraction of oxidized
HMGB1 in the effluent was much smaller. We also detected
oxidation of HMGB1 in the liver graft tissue (Fig. 6B) and serum
(Fig. 6D) of rats 24 h after liver transplantation, suggesting a
reduction of its inflammatory potential after ischemia and
reperfusion.
Discussion
HMGB1 has been proposed to induce the inflammatory
response in hepatic I/R injury but its role in this process is not
fully understood. Furthermore, HMGB1 is often post-translation-
ally modified [7], which might affect its function. In this study, we
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induced the expression of inflammatory mediators by cultured
macrophages; (2) oxidation of HMGB1 using H2O2 reduced its
pro-inflammatory potential both in vitro and in vivo; and (3)
oxidation of HMGB1 took place during prolonged cold ischemia
and reperfusion in liver transplantation.
HMGB1 is released from ischemic liver cells and has been
shown to mediate the inflammation and injury in liver I/R injury
[16,20]. In the present study, we demonstrated that cold storage of
the liver graft and liver transplantation could induce HMGB1
translocation and release. This finding is consistent with that of
Ilmakunnas et al. They reported that HMGB1 levels peaked
10 min after reperfusion and began to decrease progressively
within 1 to 2 hours after reperfusion [33]. Effluent HMGB1
obtained from liver grafts during cold ischemia significantly
upregulated the expression of inflammatory mediators by cultured
macrophages. This finding provides direct evidence that HMGB1
can participate in the meditation of inflammation in hepatic I/R
injury. HMGB1 released from damaged liver cells, may exert the
same effect and cause the synthesis of pro-inflammatory cytokine
in livers subjected to I/R injury in vivo. This hypothesis is
supported by a previous observation from Tsung et al. [16]. In
their model, HMGB1 levels were increased during liver I/R as
early as 1 h after reperfusion, and neutralizing antibody to
HMGB1 decreased production of TNF-a, IL-6 and inducible NO
synthase (iNOS) in hepatic warm I/R.
HMGB1 contains three cysteines, Cys23, 45, and 106. Cys23
and 45 induce conformational changes in response to oxidative
stress, whereas Cys106 is critical for HMGB1 translocation from
nucleus to cytoplasm [25]. We previously demonstrated that
HMGB1 was translocated from the nucleus to the cytoplasm in
hepatocytes as early as 4 h after cold ischemia [28]. In the present
study, we observed that oxidation of HMGB1 occurred upon
prolonged cold ischemia in parallel with its translocation into
cytoplasm and the release into the effluent. Oxidation of HMGB1
was also present in liver tissue and serum obtained 24 h after
reoxygenation. In contrast, oxidized HMGB1 was undetectable in
normal liver tissue. Our observations support the findings of
Ilmakunnas and Sahu [33,34], demonstrating that HMGB1 is
present partially in an oxidized form during liver I/R.
We were interested to elucidate whether oxidation of HMGB1
could attenuate its inflammatory potential. For oxidation or
Figure 1. Graft effluent stimulates the synthesis of inflammatory cytokines in peritoneal macrophages. (A) Macrophages were
stimulated with effluent (100 ml) and the supernatants were examined for levels of inflammatory cytokines (TNF-a and IL-6) by ELISA 6 h after
stimulation. (B) Quantitative PCR was performed to determine the mRNA expression levels of TNF-a and IL-6. TNF-a and IL-6 concentration in the
supernatants, as well as intracellular TNF-a and IL-6 mRNA levels were significantly increased after stimulation with effluent obtained after 8 h of cold
storage. Data are shown as mean 6 SD. *p,0.05, **p,0.001. E, effluent; TNF-a, tumor necrosis factor-alpha; IL, interleukin; HGPRT, hypoxanthine-
guanine phosphoribosyltransferase; ELISA, enzyme-linked immunosorbent assay; PCR, polymerase chain reaction.
doi:10.1371/journal.pone.0035379.g001
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H2O2 at a concentration of 50 mM, which is normally found
within ischemic/reperfused liver tissue [35]. One limitation to
this experiment is that treatment with H2O2 may oxidize
HMGB1 not only Cys residues but also at other regions which
needed for its stimulatory function. First we demonstrated that
oxidation of effluent HMGB1 with H2O2 reduced the inflam-
matory response in the macrophage bioassay in vitro. This
observation is supported by the results from other groups [26,36].
The reduced inflammatory activity may be caused by the
oxidation of Cys106 within the HMGB1 molecule. Kazama et
al. reported that oxidation of Cys106 is necessary to block the
stimulatory activity of HMGB1 [26]. Cys106 has been recently
implicated in the binding of HMGB1 to macrophages toll-like
receptor 4 [36]. Yang and colleagues observed that other
alterations such as the mutation of Cys106 also prevented the
HMGB1-induced activation of and cytokine release by cultured
macrophages [36].
To determine whether oxidation of HMGB1 could attenuate
the inflammatory response also in vivo, we injected rHMGB1 as
well as oxidized rHMGB1 and observed the mRNA expression of
pro-inflammatory cytokines in different organs. Abraham et al.
reported that administration of rHMGB1 to mice led to an acute
inflammatory injury of the lungs with neutrophil accumulation,
the development of lung edema and increased pulmonary
production of inflammatory cytokines [32]. Application of lower
Figure 2. Pro-inflammatory activity of graft effluent is decreased after HMGB1 depletion. HMGB1 concentration in effluent was detected
by ELISA-assay (A) or western blot (B), respectively. Effluent HMGB1 was significantly increased as early as 8 h and then upregulated in a time-
dependent manner up to 24 h (*p,0.001, **p,0.0001 vs 0 h). (C) The concentration of HMGB1 in effluent obtained after 24 h of cold storage was
drastically reduced after HMGB1 depletion using immunoprecipitation. Lane 1–2 showed the HMGB1 in effluent. Lane 3–4 displayed the HMGB1 in
flow-through after HMGB1 depletion. (D) Rat peritoneal macrophages were cultured in the presence of effluent (100 ml), or HMGB1-depleted effluent
(flow-through; 100 ml) for 6 h. The inflammatory activity of effluent was markedly decreased after HMGB1 depletion when compared with complete
effluent. The experiment was performed in triplicates with similar results. Data are shown as mean 6 SD. *p,0.001, **p,0.0001 vs blank control;
# p,0.001 vs HMGB1-depleted effluent. HMGB1, high mobility group box 1; TNF-a, tumor necrosis factor-alpha; IL, interleukin.
doi:10.1371/journal.pone.0035379.g002
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35379Figure 3. HMGB1 inflammatory activity is attenuated after oxidation in vitro. (A) HMGB1 was firstly extracted from effluent obtained after
24 h of cold storage and then treated with H2O2 (50 mM) for 1 h on ice. Oxidized HMGB1 was separated on a non-reducing SDS-PAGE gel and
detected by western blot with a polyclonal anti-HMGB1 antibody. (B) The gray value of bands was calculated by ImageJ. The relative amount of
oxidized HMGB1 was expressed by oxidized HMGB1/total HMGB1. Macrophages were stimulated with effluent HMGB1 (0.5 mg/ml) or oxidized
HMGB1 (effluent HMGB1 pretreated with H2O2; 0.5 mg/ml) for 6 h. TNF-a and IL-6 concentration in the supernatants (C), as well as intracellular TNF-a
and IL-6 mRNA levels (D) were then determined. Effluent HMGB1 pretreated with H2O2 significantly attenuated its inflammatory activity. The
experiment was performed in triplicates with similar results. Data are shown as mean 6 SD. *p,0.001, **p,0.0001 vs blank control; # p,0.001 vs
HMGB1+H2O2 group. HMGB1, high mobility group box 1; TNF-a, tumor necrosis factor-alpha; IL, interleukin; HGPRT, hypoxanthine-guanine
phosphoribosyltransferase; Ox, oxidized; Red, reduced.
doi:10.1371/journal.pone.0035379.g003
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symptoms as observed in animals with systemic inflammatory
syndrome e.g. after endotoxemia. High doses of HMGB1 (i.e.,
500 mg/mouse) were lethal for mice [11]. We used a dose of
350 mg/rat (1.2 mg/kg), which is in a similar range as used by
others in mice. The inflammatory response, as measured by
TNF-a and IL-6 mRNA expression, was significantly increased in
lung and PBMC, but not in other organs 6 h after HMGB1
administration. In contrast, injection of oxidized HMGB1
attenuated the expression of both cytokines in both lung and
PBMC. Taken together, oxidation of HMGB1 reduced its
inflammatory activity both in vitro and in vivo.
However, liver I/R injury may also induce other posttransla-
tional modifications of HMGB1. Unmodified HMGB1, or other
forms of HMGB1, such as acetylated, phosphorylated and methy-
lated HMGB1 may also exist in extracellular space. These forms of
HMGB1 have stimulatory activity [8,12,14] and may trigger the
inflammation in liver I/R injury [16]. Thus, although oxidized
HMGB1 is produced upon reperfusion and attenuates its pro-
inflammatory activity, other forms of HMGB1 that are present in
such settings are likely to override the inhibitory effects of oxidized
HMGB1 during liver I/R.
Insummary,HMGB1releasedintotheeffluentduringprolonged
cold saline preservation, contributed to the pro-inflammatory
activity in a macrophage assay. Oxidation of HMGB1 as induced
by H2O2-pretreatment attenuated its inflammatory activity both in
vitro and in vivo. Oxidation of HMGB1 as induced during
prolonged ischemia and by reoxygenation during reperfusion in
vivo might also attenuate its pro-inflammatory activity.
These observations confirm that HMGB1 post-translational
modifications are decisive for the pro-inflammatory activity. Our
findings also call for future studies to investigate the mechanism of
the inhibitory effect of oxidized HMGB1 on the pro-inflammatory
potential in more depth.
Materials and Methods
Ethics statement
All animal procedures were carried out according to the
German Animal Welfare Legislation. Animal experiments were
approved by the Bezirksregierung Du ¨sseldorf (Approval number:
G893/06).
Experimental design
The experiments were designed to investigate whether effluent
HMGB1 may act as inflammatory cytokine and posttranslational
oxidation of HMGB1-protein may attenuate its inflammatory
potential. We also examined whether hepatic HMGB1 was
oxidized during cold ischemia and reperfusion after liver
transplantation.
To determine whether effluent HMGB1 could trigger the
synthesis of pro-inflammatory cytokines by cultured macrophage,
effluent was collected after 24 h of cold storage of liver grafts and
effluent HMGB1 was depleted by immunoprecipitation. Perito-
neal macrophages were cultured for 6 h alone or in the presence of
effluent or effluent after depletion of HMGB1. TNF-a and IL-6
concentration in culture supernatants and their mRNA expression
in macrophages were assayed by ELISA or quantitative PCR,
respectively.
To determine whether oxidized HMGB1 could attenuate the
synthesis of pro-inflammatory cytokines by cultured macrophages,
HMGB1 was firstly extracted from effluent obtained after 24 h of
cold storage by immunoprecipitation and then oxidized via
pretreatment with H2O2. Peritoneal macrophages were cultured
alone or in the presence of effluent HMGB1 or oxidized HMGB1
(effluent HMGB1 pretreated with H2O2). The synthesis of TNF-a
and IL-6 was measured as described above.
To determine whether oxidized HMGB1 could attenuate its
stimulatory activity in vivo, recombinant HMGB1 was oxidized
via pretreatment with H2O2. Oxidized HMGB1 protein or
Figure 4. HMGB1 inflammatory activity is attenuated after oxidation in vivo. Recombinant HMGB1 (rHMGB1) was pretreated with 50 mM
H2O2 for 1 h on ice. TNF-a mRNA and IL-6 mRNA expression levels were measured by quantitative PCR in liver, lung, heart, kidney and PBMC 6 h after
injecting either unmodified (rHMGB1; 350 mg/rat) or oxidized HMGB1 (rHMGB1 pretreated with H2O2; 350 mg/rat) to naive rats. mRNA levels for TNF-a
(A) and IL-6 (B) were significantly elevated in lung and PBMC after administration of rHMGB1. In contrast, rHMGB1 pretreated with H2O2 did not
upregulate the expression of TNF-a and IL-6. Data are shown as mean 6 SD. *p,0.001 vs HMGB1+H2O2 group. HMGB1, high mobility group box 1;
TNF-a, tumor necrosis factor-alpha; IL, interleukin; HGPRT, hypoxanthine-guanine phosphoribosyltransferase; PBMC, peripheral blood mononuclear
cells; PCR, polymerase chain reaction.
doi:10.1371/journal.pone.0035379.g004
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itoneally (i.p.). Determination of TNF-a and IL-6 expression was
used as indicator of the inflammatory response.
To determine whether oxidized HMGB1 was generated during
cold ischemia and reperfusion in liver transplantation, oxidation of
HMGB1 in liver tissue and effluent samples obtained during cold
preserved liver grafts as well as in liver tissue and serum samples
obtained 24 h after transplantation were examined.
Animals
Male inbred Lewis rats, purchased from Central Animal Facility
of the University Hospital Essen, weighing between 250,300 g,
were used for this study. All animals were housed under standard
animal care conditions and had free access to water and rat chow
ad libitum.
Isolation and perfusion of rat liver
Livers were isolated and perfused by the method outlined by us
in details earlier [28]. At specific time intervals, the livers were
Figure 5. Liver transplantation causes HMGB1 translocation and release. (A) Immunohistochemical staining of HMGB1 demonstrated that
HMGB1 was translocated from nucleus to cytoplasm in hepatocytes after liver transplantation (a–b, original magnification 6100; c–d, original
magnification 6200). Representative images from six rats/group were selected. (B) Expression levels of HMGB1 protein in grafts were significantly
increased after liver transplantation. The results were obtained using liver homogenates from six individual animals. (C) Serum concentrations of
HMGB1, as measured by ELISA were significantly increased 24 h after liver transplantation. (D) Liver transplantation caused a severe hepatocellular
injury as indicated by higher release of AST. (E) Serum HMGB1 levels positively correlated with AST levels in the serum. Data are shown as mean 6 SD.
*p,0.05, **p,0.001 vs normal control rats. HMGB1, high mobility group box 1; AST, aspartate aminotransferase; GAPDH, glyceraldehyde-3-
phosphate dehydrogenase; LTx, liver transplantation; ELISA, enzyme-linked immunosorbent assay.
doi:10.1371/journal.pone.0035379.g005
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e35379Figure 6. Oxidized HMGB1 is produced after prolonged cold ischemia and reperfusion in liver transplantation. (A–B) Total hepatic
proteins (10 mg) were separated on a non-reducing SDS-PAGE gel and HMGB1 protein was detected by western blot. The gray value of bands was
calculated by ImageJ. The relative amount of oxidized HMGB1 was expressed by oxidized HMGB1/total HMGB1. Oxidized HMGB1 was produced in
liver graft during cold storage (A) and 24 h after transplantation (B) Each lane represented a separate animal. The results were obtained using liver
homogenates from six individual animals per each observation time point. Data are shown as mean 6 SD. *p,0.001 vs 0 h. Effluent (C) or serum
Oxidation HMGB1 and Hepatic I/R Injury
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through the portal vein and 1.5 ml effluent was collected from the
infrahepatic vena cava. Samples were centrifuged thereafter at
4uC to remove erythrocytes.
Preparation and treatment of effluent HMGB1
Effluent was collected at defined time-points and 100 ml effluent
was used for treatment of macrophages. In defined experiments,
HMGB1 was depleted from effluent obtained after 24 h of cold
storage by immunoprecipitation analysis. Depletion of HMGB1
was verified by immunoblotting. Effluent HMGB1 was treated
with 50 mMH 2O2 for 1 h on ice. Oxidized HMGB1 was
separated by non-reducing SDS-PAGE gel and detected by
immunoblotting.
Immunoprecipitation analysis
Crosslink immunoprecipitation kit was bought from Pierce
(Thermo Pierce, Rockford, USA). Immunoprecipitation experi-
ments were performed according to the instructions of the
manufacturer. Briefly, HMGB1 antibody (10 mg; Abcam, Cam-
bridge, UK) was firstly incubated with protein A/G plus agarose
resin (20 ml), and then was covalently cross-linked onto protein A/
G resin by 450 mM DSS at room temperature for 1 h. Normal
rabbit IgG (Sigma-Aldrich, St.Louis, USA) was used as a negative
control. Effluent obtained after 24 h of cold storage was firstly pre-
cleared using the control agarose resin to reduce nonspecific
protein binding. Precleared effluent was incubated with protein A/
G beads coupling with anti-HMGB1 at 4uC overnight. The flow-
through was collected by centrifugation for HMGB1 depletion
experiments. Effluent HMGB1 was eluted from beads by using
antigen elution buffer for pro-inflammatory activity analysis.
Administration of HMGB1
Recombinant HMGB1 (rHMGB1) (Sigma-Aldrich, St.Louis,
USA) was pretreated with 50 mMH 2O2 for 1 h on ice. Oxidized
HMGB1 protein or HMGB1 protein was administered in a single
dose by intraperitoneally (i.p.) injection at a concentration of
350 mg per rat (1.2 mg/kg) in 1 ml of PBS, respectively. Control
rats were given 50 mMH 2O2 in 1 ml of PBS. Rats were scarified
and livers, kidneys, lungs, hearts, blood sampling were harvested
6 h after the i.p. injection. Peripheral blood mononuclear cells
(PBMC) were separated by Ficoll density gradient centrifugation
(Biocoll; Biochrom AG, Berlin, Germany).
Isolation and culture of peritoneal macrophages
Isolation and culture of peritoneal macrophages were per-
formed as described previously [37]. Peritoneal macrophages were
cultured alone or in the presence of effluent (100 ml), effluent
depleted of HMGB1 (100 ml), effluent HMGB1 (0.5 mg/ml), or
oxidized HMGB1 (effluent HMGB1 pretreated with H2O2;
0.5 mg/ml).
Liver transplantation
Liver grafts were subjected to 6 h cold ischemia prior to the
transplantation procedure based on the method described by
Kamada [38]. Rats were sacrificed 24 h after transplantation. To
assess hepatocellular injury following liver transplatation, aspartate
aminotransferase (AST) was measured in serum using an
Automated Chemical Analyzer (Bayer; Leverkusen, Germany).
Gel electrophoresis and western blot
Ten mg total proteins or 10 ml effluent proteins were loaded per
well and separated on reducing or non-reducing 12% gel by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) followed by western blot and staining with HMGB1
antibody (1:1000; Abcam, Cambridge, UK) or GAPDH antibody
(1:20000; Sigma-Aldrich, St.Louis, USA). Signals were detected
with Lumi-Light Western Blot Substrate (Roche, Mannheim,
Germany) and exposed to high sensitivity films (GE Healthcare,
Buckinghamshire, UK) for autoradiography. The gray value of
bands was calculated by ImageJ 1.43 G (NIH, Bethesda, USA).
HMGB1 immunohistochemistry
HMGB1 immunohistochemical analysis was performed as
described previously [28]. After de-paraffinization and rehydra-
tion, antigen retrieval was performed using citrate-EDTA buffer
(10 mM citric acid, 2 mM EDTA, 0.05% Tween 20, pH 6.2) for
20 mins at 100uC. Then sections were incubated with HMGB1
antibody (1:500; Abcam, Cambridge, UK) for 1 h at room
temperature, followed by detection using the PowerVision System
(ImmunoLogic, Duiven, Netherlands). The percentage of hepato-
cytes with only cytoplasmic HMGB1 staining out of the total
number of hepatocytes was calculated.
Enzyme-linked immunosorbent assay (ELISA)
Effluent HMGB1 or serum HMGB1 was measured with a
commercial ELISA-assay (Shino-Test, Kanagawa, Japan). IL-6
and TNF-a concentration in culture supernatants were measured
using commercially available ELISA kits (R&D Systems Europe,
Abingdon, UK). All procedures were performed according to the
instructions of the manufacturers.
Quantitative polymerase chain reaction (PCR)
Total RNA was extracted from liver tissue or cultured cells
using the RNeasy kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instruction. cDNA synthesis was performed using
the First-Strand cDNA synthesis kit (Invitrogen, Carlsbad, USA).
The sense, antisense primers and universal probe library (Roche
Diagnostics GmbH, Mannheim, Germany) used for the analysis of
the expression of TNF-a, IL-6 and hypoxanthine-guanine
phosphoribosyltransferase (HGPRT) were as follows: TNF-a:5 9-
TGAACTTCGGGGTGATCG-39,5 9-GGGCTTGTCACTC-
GAGTTTT-39 and probe #63; IL-6: 59-CCTGGAGTTTGT-
GAAGAACAACT-39,5 9-GGAAGTTGGGGTAGGAAGGA-39
and probe #106; HGPRT: 59-GACCGGTTCTGTCATGTCG-
39,5 9-ACCTGGTTCATCATCACTAATCAC-39 and probe
#95. Primers and probes were mixed with Brilliant probe-based
QPCR Master Mix (Agilent, Santa Clara, USA) and then diluted
with distilled deionized water up to 20 ml. An Mx3000P QPCR
System (Stratagene, La Jolla, USA) was used for quantitative PCR.
Thermal cycling conditions consisted of a 10 min template
denaturation step at 95uC, followed by 50 cycles of 95uC for
30 s, 50uC for 30 s and 72uC for 30 s. Each gene expression was
normalized with HGPRT mRNA content.
proteins (D) (10 ml) were separated on a non-reducing SDS-PAGE gel. The gray value of bands was calculated by ImageJ. The relative amount of
oxidized HMGB1 was expressed by oxidized HMGB1/total HMGB1. Oxidized HMGB1 was found in effluent after 16 h cold ischemic storage of liver and
in serum obtained 24 h after transplantation. The results shown are representative of six animals/group. Data are shown as mean 6 SD. *p,0.001 vs
normal control rats. HMGB1, high mobility group box 1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; Ox, oxidized; Red, reduced; Con,
normal control; LTx, liver transplantation.
doi:10.1371/journal.pone.0035379.g006
Oxidation HMGB1 and Hepatic I/R Injury
PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e35379Statistical analysis
Data were expressed as means 6 SD. Differences between
groups were evaluated for significance by one way ANOVA
analysis. All tests were performed using SigmaStat v3.5 (Systat-
Software, Erkrath, Germany). A p-value below 0.05 was
considered statistically significant.
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